NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
MS & Immune DisordersAutologous Stem Cell Transplantation Inducing Durable Remission in Relapsing Tumefactive Multiple Sclerosis
Andrea Waser, BBiomedSc, MBBS; Mike Boggild, MD, FRACPAndrea Waser, BBiomedSc, MBBS; Mike Boggild, MD, FRACP- MS & Immune Disorders
MS Minute: Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
Sarah Conway, MD; Kristin Galetta, MD, MSeDSarah Conway, MD; Kristin Galetta, MD, MSeD - MS & Immune Disorders
Updates to the McDonald Diagnostic Criteria for Multiple Sclerosis
Kelsey Stefan, MD; Leena Wahajat, BSKelsey Stefan, MD; Leena Wahajat, BS